Target intelligence / Profile preview

Endoplasmic reticulum lumenal protein 29 pseudogene 1 (ERP29P1)

Target
ERP29P1
Molecular classification
Other (Pseudogene)
01

Overview

Endoplasmic reticulum lumenal protein 29 pseudogene 1 (ERP29P1), also known as ERP28P, is a processed pseudogene found in the human genome[3]. Unlike functional protein-coding genes, pseudogenes like ERP29P1 have lost their coding potential due to disabling mutations or lack of regulatory sequences, and thus do not encode functional proteins[2][3]. Pseudogenes may sometimes play regulatory roles, such as acting as microRNA decoys or producing non-coding RNAs that influence the expression of related genes, but no evidence is available that ERP29P1 itself serves such a regulatory function[2][3]. The functional gene related to ERP29P1 is ERp29, an endoplasmic reticulum protein involved in protein folding and secretion, and which has been implicated in cancer biology and ER stress responses[1]. However, ERP29P1 itself is considered a non-functional pseudogene, not a valid drug target, biomarker, or receptor[3][2]. Key Notes on Accuracy: ERP29P1 is a pseudogene, not an active protein, enzyme, receptor, transporter, or traditional therapeutic target[3][2]. It should not be confused with the functional ERp29 protein, which is sometimes discussed as a target in cancer and protein homeostasis research[1]. No clinical, therapeutic, or biomarker data supports any role for ERP29P1 itself. If this molecule was referenced as a direct drug or diagnostic target, this is *incorrect*.

Other names
ERP28P
02

Biological functions

Other (Potential regulatory RNA function based on pseudogene biology[2])
03

Disease associations

Other (No direct implication; parent gene involvement suggested in cancer, but not the pseudogene itself[2])Note: The parent gene ERp29 (not ERP29P1) is associated with cancer and protein homeostasis, but ERP29P1 specifically, as a pseudogene, has not been described as a disease driver[2][3].

Beyond the preview

Go deeper on Endoplasmic reticulum lumenal protein 29 pseudogene 1 (ERP29P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endoplasmic reticulum lumenal protein 29 pseudogene 1 (ERP29P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call